Kintara Therapeutics (KTRA)

Kintara Therapeutics (KTRA) Financial Statements


Kintara Therapeutics Financial Overview

Kintara Therapeutics's market cap is currently ―. The company's EPS TTM is $-11.59; its P/E ratio is -0.30; Kintara Therapeutics is scheduled to report earnings on September 25, 2023, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ -3.26M$ -3.45M-$ -5.46M$ -5.36M
EBITDA$ -2.17M$ -2.36M-$ -5.44M$ -5.34M
Net Income Common Stockholders$ -3.27M$ -3.46M-$ -5.45M$ -5.36M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.04M$ 4.87M-$ 11.78M$ 8.84M
Total Assets$ 6.74M$ 9.92M-$ 15.95M$ 12.80M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.04M$ -4.87M$ 0.00$ -11.78M$ -8.84M
Total Liabilities$ 2.95M$ 3.32M-$ 4.15M$ 3.41M
Stockholders Equity$ 3.79M$ 6.60M-$ 11.79M$ 9.39M
Cash Flow-
Free Cash Flow$ -1.83M$ -2.16M-$ -4.99M$ -5.22M
Operating Cash Flow$ -1.83M$ -2.16M-$ -4.99M$ -5.22M
Investing Cash Flow---$ 0.00$ 0.00
Financing Cash Flow$ -2.00K$ -50.00K-$ 7.93M$ -2.00K
Currency in USD

Kintara Therapeutics Earnings and Revenue History

Kintara Therapeutics Debt to Assets

Kintara Therapeutics Cash Flow

Kintara Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis